Published AAO appeal decisions

Pharmaceutical researcher claiming EB-1A extraordinary ability asserts evidence of major contributions through highly cited publications on colorectal cancer treatment. AAO held petitioner met only two of three claimed criteria; publications in respected journals do not automatically demonstrate major significance; no evidence of substantial field impact; appeal dismissed.

Research and development manager in personal care industry sought EB-1A. Met leading or critical role criterion but failed membership, original contributions, and scholarly articles criteria. AAO declined final merits analysis due to insufficient threshold evidence.

CEO and inhaled drug delivery researcher claimed EB-1A extraordinary ability, satisfying five initial evidentiary criteria. AAO held totality of evidence insufficient for final merits determination; petitioner lacked sustained national acclaim and did not demonstrate career of acclaimed work placing him among field's very top.

Postdoctoral research scientist in pharmaceutical sciences claimed three evidentiary criteria, all met at initial stage. AAO upheld dismissal because evidence of peer review, citations, and articles did not establish sustained national or international acclaim or placement among the very top of the field as required.

Pharmaceutical research scientist sought EB-1A classification claiming three criteria. AAO dismissed appeal, finding only judging and scholarly articles met but original contributions lacked evidence of major significance and sustained national or international acclaim.

Clinical pharmacologist employed by biopharmaceutical company met three initial evidentiary criteria but lacked sustained national or international acclaim demonstrating placement among the very top of field in pharmacokinetics and pharmacodynamics; appeal dismissed on final merits.

A postdoctoral bioelectronics researcher specializing in protein nanowires sought EB-1A extraordinary ability classification. The AAO dismissed the appeal, finding the petitioner met only two of three claimed criteria and failed to demonstrate original contributions of major significance, falling short of the three-criterion threshold.

A biomedical engineer researcher sought EB-1A classification. The AAO affirmed that he met three initial criteria but dismissed his appeal, finding he failed to demonstrate sustained national or international acclaim or that he ranks among the very top of his field despite accomplishments.

A director of program management in biomedical sciences sought EB-1A classification. He met three criteria: peer review, scholarly articles, and leading role. The AAO found the evidence insufficient to demonstrate sustained national or international acclaim or placement at the very top of the field, dismissing the appeal.

A biomolecular researcher claimed extraordinary ability and met three initial criteria: judging, original contributions, and scholarly articles. AAO proceeded to final merits analysis and found record did not establish sustained national or international acclaim or top-tier achievement.

A chemistry, manufacturing, and controls regulatory affairs researcher met three evidentiary criteria (published material, judging, scholarly articles). However, on final merits the AAO found insufficient evidence of sustained national acclaim or that she ranked among the very top of her field. Limited press coverage and peer review activities did not demonstrate differentiation from peers. Appeal dismissed.

Biotechnologist in immunology sought EB-1A extraordinary ability classification. AAO confirmed petitioner met three evidentiary criteria (judging, scholarly articles, leading role) but dismissed appeal because totality of evidence failed to establish sustained national or international acclaim or placement among the very top of the field.

Pharmaceutical company petitioner sought to classify beneficiary as having extraordinary ability in their field. Although beneficiary met three initial criteria—judging, scholarly articles, and critical role—the AAO found she did not demonstrate sustained national or international acclaim or that she ranks among the very top of her field based on totality of evidence.

A postdoctoral researcher in biomedical engineering working on gene therapy sought EB-1A extraordinary ability. The AAO confirmed two criteria met: judging and scholarly articles. The petitioner's claimed original contributions in gene therapy delivery were rejected as lacking evidence of major significance or field impact, failing the threshold of three criteria.

A senior director in project management for a pharmaceutical company met three required criteria: judging, scholarly articles, and high salary. The AAO affirmed on final merits that his sustained international acclaim, conference presentations, R&D facility design, and field recognition demonstrate he is among the very top.

A molecular diagnostics company employed a scientist claiming extraordinary ability in sciences. Director found four criteria met, but AAO reversed original contributions and high salary findings. With only two criteria solidly met and no showing of sustained national acclaim at field's top, appeal dismissed.

Scientist in cancer research self-petitioner sought EB-1A extraordinary ability classification. AAO found petitioner met zero of criteria analyzed; while work was valuable, record lacked evidence of sustained national or international acclaim placing him at field's top.